These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 21518979)
41. Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: comparison with 3-hydroxy-3-methylglutaryl-coa reductase inhibitors. Hiyoshi H; Yanagimachi M; Ito M; Ohtsuka I; Yoshida I; Saeki T; Tanaka H J Lipid Res; 2000 Jul; 41(7):1136-44. PubMed ID: 10884296 [TBL] [Abstract][Full Text] [Related]
42. Statins for patients with type 2 diabetes. Pimpinella G; Bertini Malgarini R; Martini N Lancet; 2004 Nov 27-Dec 3; 364(9449):1933; author reply 1933. PubMed ID: 15566999 [No Abstract] [Full Text] [Related]
44. [Statins--the panacea of the turn of the century?]. Lubiszewska B; Ruzyłło W Pol Arch Med Wewn; 2004 May; 111(5):617-24. PubMed ID: 15508815 [No Abstract] [Full Text] [Related]
46. The nature of the statins. Jones PH Circulation; 2000 Feb; 101(8):E89. PubMed ID: 10694539 [No Abstract] [Full Text] [Related]
47. [SBU should investigate what is an evidence-based and cost-effective use of statins]. Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B Lakartidningen; 2009 Aug 5-18; 106(32-33):1992-4. PubMed ID: 19764381 [No Abstract] [Full Text] [Related]
49. Changing the cardiovascular prevention game. Results from a large clinical trial may mean a new era of super-low LDL targets and anti-inflammatory strategies. Harv Health Lett; 2009 Jan; 34(3):6. PubMed ID: 19172762 [No Abstract] [Full Text] [Related]
50. [Statin therapy]. Hitzenberger G Wien Med Wochenschr; 2003; 153(11-12):242-3. PubMed ID: 12879631 [No Abstract] [Full Text] [Related]
52. Phenoxypropylamines: a new series of squalene synthase inhibitors. Brown GR; Butlin RJ; Chapman S; Eakin MA; Foubister AJ; Freeman S; Griffiths D; Harrison PJ; Johnson MC; Mallion KB J Med Chem; 1995 Oct; 38(21):4157-60. PubMed ID: 7473541 [No Abstract] [Full Text] [Related]
53. Update on statin drugs for lipid disorders. Simonson W Geriatr Nurs; 2018; 39(3):350-351. PubMed ID: 29776686 [No Abstract] [Full Text] [Related]
54. Statins and diabetes risk. Med Lett Drugs Ther; 2014 Sep; 56(1450):79-80. PubMed ID: 25157682 [No Abstract] [Full Text] [Related]
55. PCSK9 Inhibitors and Cardiovascular Events. Sabatine MS; Wasserman SM; Stein EA N Engl J Med; 2015 Aug; 373(8):774-5. PubMed ID: 26295078 [No Abstract] [Full Text] [Related]
56. PCSK9 Inhibitors and Cardiovascular Events. Goemann IM; Londero TM; Dora JM N Engl J Med; 2015 Aug; 373(8):773-4. PubMed ID: 26287856 [No Abstract] [Full Text] [Related]
57. Placing PRINCE in perspective. Simpson RJ JAMA; 2001 Jul; 286(1):91-3. PubMed ID: 11434833 [No Abstract] [Full Text] [Related]
58. Low-density lipoprotein cholesterol reduction and prevention of cardiovascular disease. Stein EA Mayo Clin Proc; 2009 Apr; 84(4):307-9. PubMed ID: 19339646 [No Abstract] [Full Text] [Related]
59. Update on statins and other lipid-lowering drugs. Miller CA Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910 [No Abstract] [Full Text] [Related]
60. Observing JUPITER. Trial results are likely to expand statin use and testing for CRP. Harv Heart Lett; 2009 Jan; 19(5):2. PubMed ID: 19575511 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]